Published March, 2012
By J. R. McGhee
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Advances in Experimental Medicine and Biology
Rating:
Availability: Available

The present conference is the third in a series on this topic sponsored by the NCP. The published proceedings will bring these to the attention of the research community quickly and hopefully they will stimulate new investigators to bring their talents to these problems.

---

Published March, 2012
By Janos Jako
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

Although plasma cell tumors are still an enigma, the authorprovides an excellent overview of all aspects of examinationand treatment of gammopathies, based on 30 years ofexperience examining more than 1500 patients.

---

Published March, 2012
By Edwin Cooper
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Contemporary topics in immunobiology
Rating:
Availability: Available

This fourth volume of Contemporary Topics In Immunobiology treats in vertebrate immunity. For example, cellular immunity is characterized by both specificity and memory, but it is still problematical whether vertebrate immune capacity evolved directly from invertebrates.

---

Published March, 2012
By Stanley T. Crooke and George Poste
Publisher: Springer (Springer-Verlag New York Inc.)
Series: New Horizons in Therapeutics
Rating:
Availability: Available

Recent progress has defined the cells that mediate the inflammatory response, many of the inter cellular transmitters, the receptors, signal transduction processes and regula tory mechanisms.

---

Published March, 2012
By David Escors, Karine Breckpot, Frederick Arce, Grazyna Kochan and Holly Stephenson
Publisher: Springer (Springer Basel)
Series: SpringerBriefs in Biochemistry and Molecular Biology
Rating:
Availability: Available

Gene therapy was conceived during the early and mid part of the 20th century. The authors also discuss the application of lentivector gene therapy for the treatment of cancer and autoimmune diseases, ending with the application of lentivectors in human gene therapy clinical trials.

---

Published March, 2012
By David Schlossberg
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Clinical Topics in Infectious Disease
Rating:
Availability: Available

The goal of this series is to provide an additional service to the clinician in the form of clinical information not usually assembled in one convenient volume. One type of monograph presented in this series will cover a specific infection, detailing microbiologic, research and clinical aspects.

---

Published March, 2012
By Rune E. Grubb
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Molecular Biology, Biochemistry and Biophysics Molekularbiologie, Biochemie und Biophysik
Rating:
Availability: Available

Though several recent reviews of the multifacetted problems related to immuno globulins are available, it was decided to publish this survey in the belief that know ledge of the genetic markers of immunoglobulins prqvides such information about immunoglobulin differentiation and its control as cannot be obtained from other sources.

---

Published March, 2012
By Thomas Pradeu and Elizabeth Vitanza
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

---

Published March, 2012
By T. T Hansel, Lord Morley, J. Morley, T.T. Hansel and Morley
Publisher: Springer (Birkhauser Verlag AG)
Rating:
Availability: Available

This volume brings together the latest developments in our understanding of the mechanisms of asthma, considers the safety ofbeta-adrenoceptor agonists, and explores latest developments in the use of phosphodiesterase (PDE) inhibitors in asthma therapy.

---

Published March, 2012
By Takashi Makinodan
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Comprehensive Immunology
Rating:
Availability: Available

We can also look forward to the assembling of a greater body of information explaining how and why the immune system fails with age while, paradoxically, the incidence of autoimmune diseases increases with age.

---